FRIDAY, Sept. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ...
Sept. 5 (UPI) --The Food and Drug Administration is cracking down on ingredients from unverified foreign sources that could be used in GLP-1 drugs that include Wegovy, Ozembic and Mounjaro. The drugs ...
On Sept. 5, the FDA announced an import alert and green list for glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredient (API) manufacturers. The FDA included manufacturers on the green list ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results